Biotech companies like CRISPR Therapeutics and Iovance Biotherapeutics offer long-term investment opportunities. CRISPR is developing gene therapy and editing programs, including Casgevy, with potential for steady revenue.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing